AbbVie Completes Acquisition of ImmunoGen
Go back to AbbVie Completes Acquisition of ImmunoGen| AbbVie (NYSE: ABBV) | Delayed: 261.07 +10.01 (3.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $251.06 | 52 Week High | $68.12 | |||
| Open | $252.30 | 52 Week Low | $50.71 | |||
| Day High | $261.64 | P/E | 56.63 | |||
| Day Low | $250.51 | EPS | $4.61 | |||
| Volume | 7,114,423 | |||||
| Immunogen, Inc. (NASDAQ: IMGN) | Delayed: 31.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.25 | 52 Week High | $14.22 | |||
| Open | $240.83 | 52 Week Low | $1.51 | |||
| Day High | $31.25 | P/E | N/A | |||
| Day Low | $31.25 | EPS | $-0.36 | |||
| Volume | 670,938 | |||||
